Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

XKON/354390 stock hub

XKON/354390 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/354390is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35.1B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/354390

In the news

Latest news · XKON/354390

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/354390 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

KRW

Showing 75 of 75 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 35.1B
Price	KRW 4,995
Price currency	KRW
Sic	2834
Symbol	xkon/354390
Website	https://baskhanbio.com

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.05%
Cagr3y	-5.93%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	6.79

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25.03%
200-day SMA	4,947.3
3Y total return	-16.75%
50-day SMA	4,656.9
50-day SMA vs 200-day SMA	50under200
All Time High	13,850
All Time High Change	-63.94%
All Time High Date	2022-07-20
All Time Low	3,255
All Time Low Change	53.46%
All Time Low Date	2026-03-05
ATR	272.3
Beta	0.46
Beta1y	0.28
Beta2y	0.36
Ch YTD	4.5
High	4,995
High52	6,090
High52 Date	2025-11-05
High52ch	-17.98%
Low	4,995
Low52	3,255
Low52 Date	2026-03-05
Low52ch	53.46%
Ma50ch	7.26%
Price vs 200-day SMA	0.97%
RSI	51.53
RSI Monthly	48.9
RSI Weekly	53.86
Sharpe ratio	0.3x
Sortino ratio	0.53
Tr YTD	4.5
Tr1w	0.3%
Tr3m	6.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,442,723%
Shares Insiders	49.24%
Shares Out	7,018,247

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	436.7x
Ch1w	0.3
Ch1y	25.03
Ch3m	6.28
Ch3y	-16.75
Ch6m	-0.89
Change	-0.1%
Change From Open	0
Close	5,000
Days Gap	-0.1
Dollar Volume	419,580
F Score	0
Is Primary Listing	1
Ma150	4,866.2
Ma150ch	2.65%
Ma20	5,049.8
Ma20ch	-1.08%
Open	4,995
Price Date	2026-05-07
Relative Volume	0.21x
Tr6m	-0.89%
Volume	84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/354390 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/354390 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/354390?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+49.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/354390 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.5

Neutral momentum band

Price vs 200-day MA

+1.0%

50/200-day relationship not available

Beta (5Y)

0.46

Less volatile than the market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/354390

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/354390 stock rating?

xkon/354390 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/354390 analysis?

The full report lives at /stocks/xkon/354390/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/354390?

The latest report frames xkon/354390 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/354390 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.